Immunochemistry contract laboratory services, including development, validation and analysis supporting toxicokinetics (TK), pharmacokinetics (PK), immunogenicity, and biomarker studies, with the latest high-spec technologies

Immunochemistry, or large molecule bioanalysis, is necessary to gain data on product efficacy, safety, disease state or mechanism of action, which will allow you to make informed and important decisions during biologic drug development.

Our immunochemistry experts provide this support through immunoassays, ligand binding assays supporting toxicokinetics (TK) and pharmacokinetics (PK) studies, immunogenicity, and biomarker studies. In support of clinical and preclinical studies, our scientists have extensive experience developing, validating, and implementing quantitative or qualitative Good Laboratory Practice (GLP) / non-GLP immunoassays.

Our technology and industry-leading immunochemistry expertise include developing and validating proprietary assays, implementing, and validating existing methods, optimizing methods then validating, and also validating existing immunoassay kits (Simoa, ELISA and ECL platforms).

With almost 30 years’ experience in large molecule bioanalysis, our experts are thought leaders in the global immunochemistry community with a strong knowledge of regulatory guidance and scientific background. Our GLP compliant laboratory in Manchester, UK, is equipped with the latest technology for immunoassay development such as quantitative ligand or receptor binding assays or immunoassays for use in pharmacokinetic (PK) and toxicokinetic (TK) studies. Our lab and scientists regularly work with clients from all around the world on a range of product types, including monoclonal antibodies, antibodies-drug conjugates, growth factors, hormones, and cytokines. 

Immunochemistry Lab Services

Related Services for Large Molecules
Related Services for Small Molecules
Need help or have a question?

Related Links

Discover our services

  • In vitro Toxicology Screening Services to Help Minimise Liabilities and Inform Drug Development Strategies
    Learn more 
  • Drug Tolerance Assessment and Improvement in Cell Based NAb Assays Using Response Data Modeling
    Learn more
  • Bioanalysis and Toxicology Challenges with ADC: How are They Different and New?
    Hosted by the Bioanalysis Zone
    Learn More
  • Overcoming Challenges in the Development and Validation of Biologics and Small Molecules in Ocular Tissues
    Hosted by the Bioanalysis Zone
    Learn more
  • Impact of Recent Changes to FDA Immunogenicity Draft Guidance
    Hosted by the Bioanalysis Zone
    Learn more
  • Additional webinars

Featured Bio

Valentine Barra
Scientific Director of Method Development & Bioanalytical Operations
Contact Intertek